Abstract:Ventricular septal defects (VSDs) are the most common type of congenital head diseases (CHDs). To date, the genetic causes for sporadic VSDs remain largely unknown. GATA transcription factor 4 (GATA4) is a zinc-finger transcription factor that is expressed in developing heart and adult cardiomyocytes. Mutations in the coding region of the GATA4 gene have been identified in CHD patients, including VSD. As the GATA4 factor is a dosage-sensitive regulator, we hypothesized that the promoter region variants of the GATA4 gene may be genetic causes of VSD. In this study, we analyzed the promoter region of the GATA4 gene by bidirectional sequencing in 172 VSD patients and 171 healthy controls. The results showed that 5 heterozygous sequence variants (NG_008177:g.4071T>C, NG_008177:g.4148C>A, NG_008177:g.4566C>T, NG_008177:g.4653G>T, and NG_008177:g.4690G>deletion) within the promoter region of the GATA gene were identified in 5 VSD patients, but in none of controls. One heterozygous sequence variant (g.4762C>A) was found only in one control, which may have no functional significance. A functional analysis revealed that the transcriptional activity of variant NG_008177:g.4566C>T was reduced significantly, whereas the transcriptional activities of the variants (NG_008177:g.4071T>C, NG_008177:g.4148C>A, NG_008177:g.4653G>T, and NG008177:g.4690G>deletion) were increased significantly compared with the wild-type GATA4 gene promoter. As GATA4 is a dosage-sensitive regulator during development, our data suggest that these sequence variants within the promoter region of the GATA4 gene may contribute to the VSD etiology by altering its gene expression. Additional studies in experimental animals will deepen our understanding of the genetic basis of VSD and shed light on designing novel molecular therapies for adult VSD patients carrying these variants. (Translational Research 2012;159:376-382)

Mutation P.s335x in GATA4 Reduces Its DNA Binding Affinity and Enhances Cell Apoptosis Associated with Ventricular Septal Defect

A Novel Gata4 Mutation Responsible for Congenital Ventricular Septal Defects

[A Novel GATA4 Mutation Leading to Congenital Ventricular Septal Defect].

A Novel GATA4 Loss-of-Function Mutation Associated with Congenital Ventricular Septal Defect

A Novel GATA6 Mutation in Patients with Tetralogy of Fallot or Atrial Septal Defect

Novel GATA6 Mutations Associated with Congenital Ventricular Septal Defect or Tetralogy of Fallot.

A Novel Missense Mutation Of Gata4 In A Chinese Family With Congenital Heart Disease

Functional analysis of the congenital heart disease‑associated GATA4 H436Y mutation in vitro.

Identification of Functional Mutations in GATA4 in Patients with Congenital Heart Disease

[Novel GATA4 Mutations Identified in Patients with Congenital Atrial Septal Defects].

Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis

A Novel Mutation of GATA4 (K319E) is Responsible for Familial Atrial Septal Defect and Pulmonary Valve Stenosis

Functional Analysis of Rare Variants of GATA4 Identified in Chinese Patients with Congenital Heart Defect

Genetic analysis of the promoter region of the GATA4 gene in patients with ventricular septal defects.

[Novel GATA4 Mutations Identified in Patients with Congenital Heart Disease].

Involvement Of A Novel Gata4 Mutation In Atrial Septal Defects

Mutation Screening of Gata4 Gene in CTD Patients Within Chinese Han Population.

GATA4 Transgenic Mice As an in Vivo Model of Congenital Heart Disease.

Transcription factor genes Smad4 and Gata4 cooperatively regulate cardiac valve development

Two novel missense mutations of GATA4 gene in Chinese patients with sporadic congenital heart defects

Identification of two novel GATA6 mutations in patients with nonsyndromic conotruncal heart defects.